Annual Report 2015–2016

Recommendations

Info

PGPA Rule Reference Part of Report Description Requirement Location 17AG(7)(b) A statement that “During [reporting period], [specified number] new consultancy contracts were entered into involving total actual expenditure of $[specified million]. In addition, [specified number] ongoing consultancy contracts were active during the period, involving total actual expenditure of $[specified million]”. Mandatory 100 PART 6 APPENDICES 17AG(7)(c) 17AG(7)(d) A summary of the policies and procedures for selecting and engaging consultants and the main categories of purposes for which consultants were selected and engaged. A statement that “Annual reports contain information about actual expenditure on contracts for consultancies. Information on the value of contracts and consultancies is available on the AusTender website.” Mandatory 100 Mandatory 99 Australian National Audit Office Access Clauses 17AG(8) Exempt contracts If an entity entered into a contract with a value of more than $100 000 (inclusive of GST) and the contract did not provide the Auditor-General with access to the contractor’s premises, the report must include the name of the contractor, purpose and value of the contract, and the reason why a clause allowing access was not included in the contract. If applicable, Mandatory 99 17AG(9) If an entity entered into a contract or there is a standing offer with a value greater than $10 000 (inclusive of GST) which has been exempted from being published in AusTender because it would disclose exempt matters under the FOI Act, the annual report must include a statement that the contract or standing offer has been exempted, and the value of the contract or standing offer, to the extent that doing so does not disclose the exempt matters. If applicable, Mandatory N/A Small business 17AG(10)(a) A statement that “[Name of entity] supports small business participation in the Commonwealth Government procurement market. Small and Medium Enterprises (SME) and Small Enterprise participation statistics are available on the Department of Finance’s website.” Mandatory 99 182 Annual Report of the National Health and Medical Research Council 2015–2016
PGPA Rule Reference Part of Report Description Requirement Location 17AG(10)(b) An outline of the ways in which the procurement practices of the entity support small and medium enterprises. Mandatory 99–100 17AG(10)(c) 17AD(e) 17AD(f) If the entity is considered by the Department administered by the Finance Minister as material in nature—a statement that “[Name of entity] recognises the importance of ensuring that small businesses are paid on time. The results of the Survey of Australian Government Payments to Small Business are available on the Treasury’s website.” Financial Statements Inclusion of the annual financial statements in accordance with subsection 43(4) of the Act. Other Mandatory Information If applicable, Mandatory 99 Mandatory 126–157 PART 6 APPENDICES 17AH(1)(a)(i) If the entity conducted advertising campaigns, a statement that “During [reporting period], the [name of entity] conducted the following advertising campaigns: [name of advertising campaigns undertaken]. Further information on those advertising campaigns is available at [address of entity’s website] and in the reports on Australian Government advertising prepared by the Department of Finance. Those reports are available on the Department of Finance’s website.” If applicable, Mandatory N/A 17AH(1)(a)(ii) If the entity did not conduct advertising campaigns, a statement to that effect. If applicable, Mandatory 102 17AH(1)(b) A statement that “Information on grants awarded to [name of entity] during [reporting period] is available at [address of entity’s website].” If applicable, Mandatory 10 17AH(1)(c) 17AH(1)(d) Outline of mechanisms of disability reporting, including reference to website for further information. Website reference to where the entity’s Information Publication Scheme statement pursuant to Part II of FOI Act can be found. Mandatory 112, 115 Mandatory 96 17AH(1)(e) Correction of material errors in previous annual report. If applicable, Mandatory 105 17AH(2) Information required by other legislation. Mandatory 90–91 Annual Report of the National Health and Medical Research Council 2015–2016 183
Page 1 and 2:
National Health and Medical Researc
Page 3 and 4:
A HEALTHY START TO LIFE NHMRC is co
Page 5 and 6:
CONTENTS ABOUT THE REPORT V PART 1
Page 7 and 8:
ABOUT THE REPORT This report was pr
Page 9 and 10:
PART1 OVERVIEW Chief Executive Offi
Page 11 and 12:
Structural review of NHMRC’s gran
Page 13 and 14:
During the year the NHMRC Council e
Page 15 and 16:
NHMRC’s strategy for health and m
Page 17 and 18:
RESEARCH FUNDING EXPENDITURE Fundin
Page 19 and 20:
PROMOTING EXCELLENCE THROUGH THE NH
Page 21 and 22:
Award Recipient Institution Researc
Page 23 and 24:
Award Recipient Institution Researc
Page 25 and 26:
CASE STUDY “This research is desi
Page 27 and 28:
ASSOCIATE PROFESSOR LEAH COSGROVE C
Page 29 and 30:
PROFESSOR LOUISA JORM WESTERN SYDNE
Page 31 and 32:
PART 2 PERFORMANCE REPORT Chief Exe
Page 33 and 34:
OUTCOMES AND PROGRAM STRUCTURE Thro
Page 35 and 36:
INVESTMENT Goal 5: Participate in d
Page 37 and 38:
TRANSLATION Goal 3: Develop public
Page 39 and 40:
INVESTMENT Create knowledge and bui
Page 41 and 42:
Table 3 Expenditure for Aboriginal
Page 43 and 44:
Figure 6 Expenditure by Science and
Page 45 and 46:
Targeted Calls for Research The out
Page 47 and 48:
GOAL 2: SUPPORT THE HEALTH AND MEDI
Page 49 and 50:
Table 11 People support outcomes fo
Page 51 and 52:
GOAL 3: BOOST DEMENTIA RESEARCH Boo
Page 53 and 54:
GOAL 4: SUPPORT COLLABORATIVE, MULT
Page 55 and 56:
Target 4: Finalise collaborative re
Page 57 and 58:
GOAL 6: SUPPORT RESEARCH THAT WILL
Page 59 and 60:
GOAL 7: PROMOTE ACCESS TO AND USE O
Page 61 and 62:
GOAL 8: IMPROVE THE GRANT APPLICATI
Page 63 and 64:
TRANSLATION Support the translation
Page 65 and 66:
NHMRC also established a separate a
Page 67 and 68:
GOAL 2: SUPPORT THE TRANSLATION OF
Page 69 and 70:
Target 6: Publish an updated Statem
Page 71 and 72:
In early 2016, the NHMRC completed
Page 73 and 74:
GOAL 3: DEVELOP PUBLIC AND ENVIRONM
Page 75 and 76:
Public consultation will be underta
Page 77 and 78:
GOAL 4: REMOVE BARRIERS TO COMMERCI
Page 79 and 80:
Table 17 NHMRC commitments to resea
Page 81 and 82:
Target 2: Improve processes for cli
Page 83 and 84:
GOAL 1: RETAIN HIGH ETHICAL STANDAR
Page 85 and 86:
GOAL 2: STRENGTHEN THE PROCESS FOR
Page 87 and 88:
Outcome 2: Strengthen the process f
Page 89 and 90:
Target 3: Review Ethical Guidelines
Page 91 and 92:
GOAL 4: ADMINISTER THE RESEARCH INV
Page 93 and 94:
PART 3 OPERATING ENVIRONMENT Legisl
Page 95 and 96:
CORPORATE GOVERNANCE Governance bod
Page 97 and 98:
• the Chief Medical Officer or th
Page 99 and 100:
The ERLC assesses applications for
Page 101 and 102:
EXTERNAL SCRUTINY JUDICIAL DECISION
Page 103 and 104:
In accordance with the RMF: • the
Page 105 and 106:
Table 19 Freedom of Information req
Page 107 and 108:
ACCOUNTABILITY PURCHASING AND PROCU
Page 109 and 110:
Table 21 Consultancy services let d
Page 111 and 112:
Complaints and their outcomes Of th
Page 113 and 114:
CORRECTION OF MATERIAL ERRORS IN PR
Page 115 and 116:
CASE STUDY The team studied diaphra
Page 117 and 118:
4 Part PEOPLE MANAGEMENT People 110
Page 119 and 120:
Table 24 NHMRC employee overview as
Page 121 and 122:
Consultations also raised the impor
Page 123 and 124:
LEARNING AND DEVELOPMENT NHMRC’s
Page 125 and 126:
Flexible workplace practices CASE S
Page 127 and 128:
PART 5 FINANCIAL REPORT Financial P
Page 129 and 130:
AGENCY RESOURCE STATEMENT Table 28
Page 131 and 132:
INDEPENDENT AUDITOR’S REPORT To t
Page 133 and 134:
PART 5 financial report Annual Repo
Page 135 and 136:
Statement of Financial Position as
Page 137 and 138:
Cash Flow Statement for the period
Page 139 and 140: Administered Reconciliation Schedul
Page 141 and 142: All new standards, amendments to st
Page 143 and 144: Reporting of Administered Activitie
Page 145 and 146: Income and Expenses Administered on
Page 147 and 148: Note 3.2 Non-Financial Assets Note
Page 149 and 150: Revaluations of non-financial asset
Page 151 and 152: Note 3.3 Other Payables 2016 2015 $
Page 153 and 154: Funding Note 5.1 Appropriations Not
Page 155 and 156: Note 5.3 Cash Flow Reconciliation R
Page 157 and 158: People and Relationships Note 6.1 P
Page 159 and 160: Managing Uncertainties Note 7.1 Con
Page 161 and 162: Note 7.2 Financial Instruments - Co
Page 163 and 164: Note 7.3 Administered - Financial I
Page 165 and 166: Other Information Note 8: Reporting
Page 167 and 168: 6 PART APPENDICES Appendix 1: Execu
Page 169 and 170: Executive Director, Evidence, Advic
Page 171 and 172: CHAIR OF NHMRC COUNCIL Chair Profes
Page 173 and 174: Australian Capital Territory Dr Pau
Page 175 and 176: Professor Michael Kidd AM Member wi
Page 177 and 178: APPENDIX 3: RESEARCH COMMITTEE The
Page 179 and 180: APPENDIX 5: EMBRYO RESEARCH LICENSI
Page 181 and 182: APPENDIX 7: HEALTH INNOVATION ADVIS
Page 183 and 184: APPENDIX 9: PUBLIC CONSULTATIONS Pu
Page 185 and 186: IREG IRIISS JPco-fuND JPND MREA NAB
Page 187 and 188: PGPA Rule Reference Part of Report
Page 189: PGPA Rule Reference Part of Report
Page 193 and 194: INDEX A Aboriginal and Torres Strai
Page 195 and 196: Cancer 5, 66 National Evidence Base
Page 197: S scholarships, 10, 39-41, 42 scien
show all

Annual Report 2015–2016

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?